[Federal Register Volume 85, Number 59 (Thursday, March 26, 2020)]
[Notices]
[Page 17088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06280]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-N-0001]


Preparation for International Cooperation on Cosmetics Regulation 
14th Annual Meeting; Public Meeting; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of cancellation of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing the 
cancellation of following public meeting entitled ``International 
Cooperation on Cosmetics Regulation (ICCR)--Preparation for ICCR-14 
Meeting.'' The purpose of the public meeting was to invite public input 
on various topics pertaining to the regulation of cosmetics.

DATES: The public meeting was to be held on April 14, 2020, from 2 p.m. 
to 4 p.m.

ADDRESSES: The public meeting was to be held at the Food and Drug 
Administration, Center for Food Safety and Applied Nutrition, 5001 
Campus Dr., Wiley Auditorium (first floor), College Park, MD 20740.

FOR FURTHER INFORMATION CONTACT: Deborah Smegal, Office of Cosmetics 
and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS-100), 
College Park, MD 20740, 240-402-1818, Deborah.Smegal@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: 

I. Background

    FDA, like other government agencies, is taking the necessary steps 
to ensure the Agency is prepared to continue our vital public health 
mission in the event that our day-to-day operations are impacted by the 
COVID-19 public health emergency. Therefore, we are canceling or 
postponing all non-essential meetings through the month of April. We 
will reassess on an ongoing basis for future months.
    Accordingly, the FDA public meeting entitled, ``International 
Cooperation on Cosmetics Regulation (ICCR)--Preparation for ICCR--14 
Meeting'' announced in the Federal Register of March 3, 2020 (85 FR 
12569), is canceled. Additionally, we will be closing the docket to 
public comments, since the purpose of the docket was to obtain 
information for the FDA public meeting and to help FDA prepare for the 
ICCR-14 meeting. Thus, because we are canceling the FDA public meeting, 
public comments are no longer necessary.
    As of March 20, 2020, the status of the ICCR-14 meeting itself 
remains to be determined.
    Please contact Deborah Smegal in FDA's Office of Cosmetics and 
Colors (See FOR FURTHER INFORMATION CONTACT) with questions.

    Dated: March 20, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-06280 Filed 3-25-20; 8:45 am]
 BILLING CODE 4164-01-P


